Stenocare (Denmark) Today
| STENO Stock | DKK 0.42 0.01 2.33% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
Stenocare is trading at 0.42 as of the 19th of March 2025, a 2.33 percent down since the beginning of the trading day. The stock's open price was 0.43. Stenocare has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Stenocare AS cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. The company was founded in 2017 and is headquartered in Allerd, Denmark. STENOCARE is traded on Copenhagen Stock Exchange in Denmark.. The company has 11.42 M outstanding shares. More on Stenocare AS
Moving against Stenocare Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Stenocare Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Stenocare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Stenocare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Stenocare AS (STENO) is traded on Copenhagen Exchange in Denmark and employs 4 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 106.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Stenocare's market, we take the total number of its shares issued and multiply it by Stenocare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Stenocare AS operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 11.42 M outstanding shares.
Stenocare AS has accumulated about 20.42 M in cash with (13.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.79, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Stenocare Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Stenocare is kr106.1 Million. Stenocare AS maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Stenocare Ownership Details
Stenocare AS Risk Profiles
Although Stenocare's alpha and beta are two of the key measurements used to evaluate Stenocare's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 6.9 | |||
| Standard Deviation | 11.1 | |||
| Variance | 123.23 | |||
| Risk Adjusted Performance | (0.09) |
Stenocare Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Stenocare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Stenocare Corporate Management
Elected by the shareholders, the Stenocare's board of directors comprises two types of representatives: Stenocare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stenocare. The board's role is to monitor Stenocare's management team and ensure that shareholders' interests are well served. Stenocare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stenocare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Schnegelsberg | CoFounder CEO | Profile | |
| Soren Kjaer | COO CoFounder | Profile | |
| Peter Johansen | Chief Officer | Profile | |
| Rolf Petersen | CoFounder Officer | Profile |
Other Information on Investing in Stenocare Stock
Stenocare financial ratios help investors to determine whether Stenocare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stenocare with respect to the benefits of owning Stenocare security.